Dr. Deepthi Devagudi, MD

Dr. Devagudi practices at Adventist Health Hanford in Hanford, California, part of Adventist Health.

Dr. Devagudi's NPI, 1578180618, was assigned on July 4, 2020. Dr. Devagudi graduated from Guangxi Medical University in 2006. Dr. Devagudi holds California license A186617.

Dr. Devagudi's primary practice is Adventist Health Hanford, at 115 Mall Drive, Hanford, CA 93230 in Kings County. The practice phone is (559) 582-9000.

Dr. Devagudi's primary practice is Adventist Health Hanford in Hanford, California, part of Adventist Health. Dr. Devagudi is also affiliated with Adventist Health Tulare. The medical group on file is Vituity. Dmand AI also links Dr. Devagudi to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Devagudi practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Devagudi's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Devagudi is licensed in California.

Dmand AI lists acute diabetes, bile duct problems, chest trauma, congestive heart failure, gastrointestinal obstruction, heart attack, kidney failure and liver disease among the conditions Dr. Devagudi treats.

CMS data shows 786 Medicare services from Dr. Devagudi across 6 procedure codes in 2024, for 261 Medicare patients. Medicare paid $68,382 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 261 Medicare patients who saw Dr. Devagudi in 2024. The largest group is 65 to 74, with 86 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 60% are also on Medicaid. Their average risk score is 3.19, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Devagudi's median patient age at 60, with 52% women.

In 2024, Dr. Devagudi wrote 336 Medicare Part D claims for 139 patients. 85% of them were for generic drugs. CMS names the drug for 118 of them, across 7 drugs with 11 or more claims each, at $1,261 in total drug cost. In 2023, CMS named 46 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Devagudi for performance year 2024, reported as part of a group. Dr. Devagudi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. Devagudi, published from 2021 to 2023. Dr. Devagudi's most frequent co-authors are Brian Scott Cooney, MD, Don K. Mathew, MD and Uma Murthy, MD.

Dr. Devagudi graduated from Guangxi Medical University in 2006.

Dr. Devagudi is in network with 6 carriers, including United Healthcare, Aspirus Health Plan and Blue Cross and Blue Shield of Kansas City. PPO plans come from the most carriers, 3. Check the plan with the practice before a visit.